Farallon Capital Management

Farallon Capital Management

Investment firm managing diverse assets

About Farallon Capital Management

Simplify's Rating
Why Farallon Capital Management is rated
C
Rated D+ on Competitive Edge
Rated B on Growth Potential
Rated C on Rating Differentiation

Industries

Quantitative Finance

Financial Services

Company Size

201-500

Company Stage

N/A

Total Funding

$9.7B

Headquarters

San Francisco, California

Founded

1986

Overview

Farallon Capital Management manages both public and private assets for a variety of clients, including institutional investors, high-net-worth individuals, and family offices. The firm uses a detailed bottom-up fundamental analysis to identify investment opportunities and continuously updates its strategies to remain competitive in the market. With 38 years of experience and $39 billion in assets under management, Farallon aims to provide superior risk-adjusted returns to its investors. What sets Farallon apart from its competitors is its focus on aligning the interests of its employees, investors, and business partners, which fosters a collaborative culture. The firm generates revenue through management fees and performance-based incentives, ensuring that its success is linked to the success of its clients.

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in biotechnology investments boosts Farallon's growth potential.
  • Strategic divestments in tech sector create new investment opportunities for Farallon.
  • Private credit loans offer alternative investment strategies for Farallon.

What critics are saying

  • Involvement in fossil fuels and private prisons may lead to reputational damage.
  • New stake in Ascendis Pharma exposes Farallon to pharmaceutical sector risks.
  • Financing Adani's coal port could attract criticism from environmental groups.

What makes Farallon Capital Management unique

  • Farallon Capital employs a rigorous bottom-up fundamental analysis approach for investment decisions.
  • The firm invests across all asset classes, including public and private securities.
  • Farallon Capital aligns interests with clients through performance-based incentives.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$9657.9M

Above

Industry Average

Funded Over

0 Rounds

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Company News

Tech in Asia
Nov 6th, 2024
KKR's stake in Fuji Soft blocks Bain's acquisition plans

3D Investment Partners and Farallon Capital, holding 32.7% of Fuji Soft, agreed to sell their shares to KKR for 8,800 yen (US$59) each.

The Oaklandside
Oct 17th, 2024
Mayor Thao claims coal interests are pushing for her recall

When Steyer retired from Farallon in 2012, he said it was in part because he had come to disagree with the hedge fund's big bets on fossil fuels and private prisons.

eGenesis
Sep 6th, 2024
eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant - egenesisbio.com

Cambridge, MA – eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the close of a $191 million Series D financing. Proceeds will be used to advance the company’s lead product candidate, EGEN-2784, to a first-in-human study for kidney transplant. The funding will also be used to advance … Continued

Stock Titan
Aug 14th, 2024
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering | ANAB Stock News

AnaptysBio raises $100M through stock offering at 10% premium, accelerating Phase 3 trials for ANB032 and rosnilimab in autoimmune diseases. Sanofi joins as investor, boosting confidence in pipeline potential.

Business Wire
Jul 17th, 2024
Cardurion Pharmaceuticals Announces $260 Million Series B Financing to Advance Its Pipeline of Innovative Medicines for Cardiovascular Diseases

Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of car

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Farallon Capital Management right now.

Find jobs on Simplify and start your career today

💡
We update Farallon Capital Management's jobs every 8 hours, so check again soon! Browse all jobs →